scholarly journals Pulmonary Fungal Infections Affect Patients With COVID-19

JAMA ◽  
2020 ◽  
Vol 324 (22) ◽  
pp. 2248
Author(s):  
Bridget M. Kuehn
2021 ◽  
Vol 10 (1) ◽  
pp. 450-460
Author(s):  
Zhengtu Li ◽  
Yongming Li ◽  
Yijun Chen ◽  
Jing Li ◽  
Shaoqiang Li ◽  
...  

2018 ◽  
Vol 51 (5) ◽  
pp. 350-355 ◽  
Author(s):  
Takashi Yamamichi ◽  
Hirotoshi Horio ◽  
Ayaka Asakawa ◽  
Masayuki Okui ◽  
Masahiko Harada

1970 ◽  
Vol 28 (6) ◽  
Author(s):  
Mohammad Reza Jabbari Amiri ◽  
Rora Siami ◽  
Azad Khaledi

BACKGROUND: Pulmonary tuberculosis is one of the most important health concerns. Pulmonary fungal infections have clinical and radiological characteristics similar to tuberculosis which may be easily misdiagnosed as tuberculosis. This study aimed to evaluate tuberculosis (TB) status and coinfection of TB with pulmonary fungal infections in patients referred to reference laboratory of health centers Ghaemshahr city during 2007-2017.METHODS: This cross-sectional study was conducted during eleven years, between 2007 2017, on 3577 patients with suspected TB referred to health centers of Ghaemshahr City. For isolation, sputum smear preparation and Ziehl-Neelson staining in companying with microscopy direct observation and KOH 10% + white Calcofluor staining was used. The culture of fungi was performed on Sabouraud Dextrose agar, Czapek and chrome agar media. Then, data were analyzed using SPSS software (version 16) through Student's t-test, Fisher test, and Odds Ratio. P values <0.05 were considered statistically significant.RESULTS: Of 3577 patients, 10731 smears were prepared, 3.6% (n=130) of patients were identified as smear-positive pulmonary tuberculosis, 86.4% (n=3090) were smear negative and 10% (n=357) drug-resistant TB. The mean age of patients was 48±1.8 years. With increasing age, the prevalence of TB has increased which was statistically significant (P value <0.05). Prevalence of tuberculosis in the age group over than 57 years in males and females had an ascending trend. Amongst the positive tuberculosis patients, 16/130 cases (12.3%) had the coinfection of TB with fungi microorganisms.CONCLUSION: Our findings showed the coinfection of fungi agents in patients with tuberculosis that should be considered. 


2008 ◽  
Vol 46 (11) ◽  
pp. 1733-1737 ◽  
Author(s):  
Hisham Wahba ◽  
Mylene T. Truong ◽  
Xiudong Lei ◽  
Dimitrios P. Kontoyiannis ◽  
Edith M. Marom

Author(s):  
Georgia Tunnicliffe ◽  
Matthew Wise

Pulmonary fungal infections remain relatively uncommon, although they are increasingly diagnosed as a consequence of a growing population of immunocompromised individuals, foreign travel, and improved diagnostic tools. Groups who were not previously thought to be at significant risk of invasive disease are also being recognized. The increasing incidence of fungal lung disease as a consequence of changing patient demographics means that clinicians will encounter cases in outpatient clinics, medical admission departments, and the intensive care unit with increasing frequency. As international travel increases, so too will presentations of endemic mycoses to respiratory physicians practising in the United Kingdom. Many fungi, such as Aspergillus species, are ubiquitous and can cause a spectrum of pulmonary disorders from colonization, leading to hypersensitivity reactions, to invasive disease with high mortality rates. This chapter considers commonly encountered fungi and how diseases associated with them may present.


1995 ◽  
Vol 70 (3) ◽  
pp. 135-141 ◽  
Author(s):  
M. Z�hlsdorf ◽  
M. Hesse ◽  
R. Schulten ◽  
J. van de Loo ◽  
M. von Eiff ◽  
...  

Author(s):  
Roopak Dubey ◽  
Kamal Kumar Sen ◽  
Sudhansu Sekhar Mohanty ◽  
Sangram Panda ◽  
Mayank Goyal ◽  
...  

Abstract Background The occurrence of invasive fungal infections in COVID-19 patients is on surge in countries like India. Several reports related to rhino-nasal-sinus mucormycosis in COVID patients have been published in recent times; however, very less has been reported about invasive pulmonary fungal infections caused mainly by mucor, aspergillus or invasive candida species. We aimed to present 6 sputum culture proved cases of invasive pulmonary fungal infection (four mucormycosis and two invasive candidiasis) in COVID patients, the clues for the diagnosis of fungal invasion as well as difficulties in diagnosing it due to superimposed COVID imaging features. Case presentation The HRCT imaging features of the all 6 patients showed signs of fungal invasion in the form of cavities formation in the pre-existing reverse halo lesions or development of new irregular margined soft tissue attenuating growth within the pre-existing or in newly formed cavities. Five out of six patients were diabetics. Cavities in cases 1, 2, 3 and 4 of mucormycosis were aggressive and relatively larger and showed relatively faster progression into cavities in comparison with cases 5 and 6 of invasive candidiasis. Conclusion In poorly managed diabetics or with other immunosuppressed conditions, invasive fungal infection (mucormycosis, invasive aspergillosis and invasive candidiasis) should be considered in the differential diagnosis of cavitary lung lesions.


2011 ◽  
Vol 32 (06) ◽  
pp. 661-662 ◽  
Author(s):  
John Baddley ◽  
Peter Pappas

Sign in / Sign up

Export Citation Format

Share Document